Our studies in human AD brain samples enabled us to validate these findings, demonstrating the importance of interfering with aberrant APP or Aβ-dependent signaling for prevention of cell cycle deregulation and neurodegeneration in AD. This evidence concerns the gene APP and Alzheimer disease.